What is Brucellosis Vaccines Market Scope?
Brucellosis vaccines are based on live Brucella abortus strain 19, a laboratory-derived strain attenuated by an unknown process during subculture. Brucellosis vaccines play an essential role in bovine brucellosis eradication or control programs. They have been effectively used worldwide for several years. Increasing brucella infection disease in animals like cattle, sheep, goats, and much other livestock has led to significant growth of the global brucellosis vaccine market in the forecast period.
The Brucellosis Vaccines market study is being classified by Type (DNA Vaccines, Subunit Vaccines, Vector Vaccines, B. Abortus Recombinant Mutants and Others), by Application (Cattle, Sheep, Goats, Pigs and Others) and major geographies with country level break-up.
Research Analyst at AMA predicts that Players from European and United States will contribute to the maximum growth of Global Brucellosis Vaccines market throughout the predicted period.
Merck & Co., Inc. (United States), Boehringer Ingelheim Vetmedica, Inc. (United States), Ceva (France), Bayer AG (Germany), Biogenesis-Bago (Argentina), Heska Corporation (United States), Colorado Serum (United States), Boehringer Ingelheim (Germany), SYVA Laboratorios (Spain) and Lohmann Animal Health (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Indian Immunologicals Ltd. (India) and Merial Ltd. (France).
Analyst at AMA have segmented the market study of Global Brucellosis Vaccines market by Type, Application and Region.
On the basis of geography, the market of Brucellosis Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 23rd September 2020, Technology License Agreement on “Brucella abortus S19Δ per vaccine” between ICAR- Indian Veterinary Research Institute (IVRI) and Hester Biosciences Limited. The vaccine will be of immense help in the National Control Programme on Brucellosis.
Influencing Market Trend
- Increased Demand for Fish, Eggs, Milk, and Animal Protein
- Growing Awareness about Animal Health
- Government Organizations and Associations are Raising Funding for Research and Development
- Technological Advancement and Development In Brucellosis Vaccines
- Rising Expenditure on Health Care of Companion Animals across the Globe
- High-Cost Associated with Brucellosis Vaccines
- Strict Government Regulations Regarding Vaccines
Key Target AudienceBrucellosis Vaccines Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.